These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 36913345)

  • 1. Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections.
    Sarker B; Rahaman MM; Islam MA; Alamin MH; Husain MM; Ferdousi F; Ahsan MA; Mollah MNH
    PLoS One; 2023; 18(3):e0281981. PubMed ID: 36913345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
    Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
    PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing.
    Islam MA; Kibria MK; Hossen MB; Reza MS; Tasmia SA; Tuly KF; Mosharof MP; Kabir SR; Kabir MH; Mollah MNH
    Sci Rep; 2023 Mar; 13(1):4685. PubMed ID: 36949176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.
    Mosharaf MP; Reza MS; Kibria MK; Ahmed FF; Kabir MH; Hasan S; Mollah MNH
    Sci Rep; 2022 Mar; 12(1):4279. PubMed ID: 35277538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer.
    Tuly KF; Hossen MB; Islam MA; Kibria MK; Alam MS; Harun-Or-Roshid M; Begum AA; Hasan S; Mahumud RA; Mollah MNH
    Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893423
    [No Abstract]   [Full Text] [Related]  

  • 6. IFI44 is an immune evasion biomarker for SARS-CoV-2 and
    Zheng Q; Wang D; Lin R; Lv Q; Wang W
    Front Immunol; 2022; 13():1013322. PubMed ID: 36189314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing.
    Alamin MH; Rahaman MM; Ferdousi F; Sarker A; Ali MA; Hossen MB; Sarker B; Kumar N; Mollah MNH
    PLoS One; 2024; 19(7):e0304425. PubMed ID: 39024368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Machine Learning Approach to Identify Potential miRNA-Gene Regulatory Network Contributing to the Pathogenesis of SARS-CoV-2 Infection.
    Das R; Sinnarasan VSP; Paul D; Venkatesan A
    Biochem Genet; 2024 Apr; 62(2):987-1006. PubMed ID: 37515735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches.
    Hoque MN; Sarkar MMH; Khan MA; Hossain MA; Hasan MI; Rahman MH; Habib MA; Akter S; Banu TA; Goswami B; Jahan I; Nafisa T; Molla MMA; Soliman ME; Araf Y; Khan MS; Zheng C; Islam T
    Front Immunol; 2022; 13():918692. PubMed ID: 36059456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational gene expression profiling in the exploration of biomarkers, non-coding functional RNAs and drug perturbagens for COVID-19.
    Aishwarya S; Gunasekaran K; Margret AA
    J Biomol Struct Dyn; 2022 May; 40(8):3681-3696. PubMed ID: 33228475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks.
    Xu J; Abdulsalam Khaleel R; Zaidan HK; Faisal Mutee A; Fahmi Fawy K; Gehlot A; Abbas AH; Arias Gonzáles JL; Amin AH; Ruiz-Balvin MC; Imannezhad S; Bahrami A; Akhavan-Sigari R
    Cell Cycle; 2024 Feb; 23(4):405-434. PubMed ID: 38640424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of genetic biomarkers, drug targets and agents for respiratory diseases utilising integrated bioinformatics approaches.
    Ahmed FF; Das AD; Sumi MJ; Islam MZ; Rahman MS; Rashid MH; Alyami SA; Alotaibi N; Azad AKM; Moni MA
    Sci Rep; 2023 Nov; 13(1):19072. PubMed ID: 37925496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metadata analysis to explore hub of the hub-genes highlighting their functions, pathways and regulators for cervical cancer diagnosis and therapies.
    Reza MS; Hossen MA; Harun-Or-Roshid M; Siddika MA; Kabir MH; Mollah MNH
    Discov Oncol; 2022 Aug; 13(1):79. PubMed ID: 35994213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.
    Reza MS; Harun-Or-Roshid M; Islam MA; Hossen MA; Hossain MT; Feng S; Xi W; Mollah MNH; Wei Y
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection.
    Banaganapalli B; Al-Rayes N; Awan ZA; Alsulaimany FA; Alamri AS; Elango R; Malik MZ; Shaik NA
    Comput Biol Med; 2021 Aug; 135():104570. PubMed ID: 34157472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of an autophagy interaction network based on competitive endogenous RNA reveals the key pathways and central genes of SARS-CoV-2 infection in vivo.
    Chen Z; Wang X; Li L; Han M; Wang M; Li Z; Xie X; Du H; Xie Z; Zhang H
    Microb Pathog; 2021 Sep; 158():105051. PubMed ID: 34153417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Analyses of MicroRNAs in Hamster Lung Tissues Infected by SARS-CoV-2.
    Kim WR; Park EG; Kang KW; Lee SM; Kim B; Kim HS
    Mol Cells; 2020 Nov; 43(11):953-963. PubMed ID: 33199671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics screening of colorectal-cancer causing molecular signatures through gene expression profiles to discover therapeutic targets and candidate agents.
    Horaira MA; Islam MA; Kibria MK; Alam MJ; Kabir SR; Mollah MNH
    BMC Med Genomics; 2023 Mar; 16(1):64. PubMed ID: 36991484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics and system biology approach to identify the influences among COVID-19, influenza, and HIV on the regulation of gene expression.
    Zhang Z; Jin H; Zhang X; Bai M; Zheng K; Tian J; Deng B; Mao L; Qiu P; Huang B
    Front Immunol; 2024; 15():1369311. PubMed ID: 38601162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential microRNA expression in the peripheral blood from human patients with COVID-19.
    Li C; Hu X; Li L; Li JH
    J Clin Lab Anal; 2020 Oct; 34(10):e23590. PubMed ID: 32960473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.